Whereas ideal ADC target antigens would be completely tumor specific, many ADC targets, like TROP2 (93), are expressed by normal tissue at levels that may drive significant target-mediated toxicity, resulting in on-target off-tumor toxicity. Here, TACSTD2 is linked to neoplasm.